Mosaic ImmunoEngineering, Inc. (CPMV)
PNK · Healthcare · Biotechnology
$0.09
+0.00%
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
Market Cap
$615,581.65
Shares Outstanding
7.2M
Exchange
PNK
Currency
USD
About Mosaic ImmunoEngineering, Inc.
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (144K) | (148K) | (155K) | (157K) |
| Net Income | (165K) | (169K) | (175K) | (177K) |
| Diluted EPS | $-0.02 | N/A | $-0.02 | $-0.02 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (2.6M) | (1.4M) | (880K) | (616K) |
| Net Income | (2.4M) | (1.0M) | (922K) | (688K) |
| Diluted EPS | $-0.33 | $-0.14 | $-0.13 | $-0.10 |